BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2654025)

  • 1. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
    Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
    Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.
    Andrews CW; Jessup JM; Goldman H; Hayes DF; Kufe DW; O'Hara CJ; Steele GD
    Cancer; 1993 Dec; 72(11):3185-90. PubMed ID: 7694786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
    Sjöqvist U; Ost A; Löfberg R
    Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the tumor-associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon.
    Wolf BC; D'Emilia JC; Salem RR; DeCoste D; Sears HF; Gottlieb LS; Steele GD
    J Natl Cancer Inst; 1989 Dec; 81(24):1913-7. PubMed ID: 2593169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal carcinoma-associated antigen detected by a monoclonal antibody in dysplasia and adenocarcinoma associated with chronic ulcerative colitis.
    Olding LB; Ahren C; Thurin J; Karlsson KA; Svalander C; Koprowski H
    Int J Cancer; 1985 Aug; 36(2):131-6. PubMed ID: 4018908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.
    Simpson JF; Primus FJ; Schlom J
    Int J Biol Markers; 1991; 6(2):83-90. PubMed ID: 1716293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
    Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
    Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistologic study of ulcerative colitis with monoclonal antibodies against tumor-associated and/or differentiation antigens.
    Cooper HS; Steplewski Z
    Gastroenterology; 1988 Sep; 95(3):686-93. PubMed ID: 3165075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis.
    Saclarides TJ; Jakate SM; Coon JS; Bhattacharyya AK; Dominguez JM; Szeluga DJ; Weinstein RS
    Dis Colon Rectum; 1992 Aug; 35(8):747-52. PubMed ID: 1353719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialomucins in the assessment of dysplasia and cancer-risk patients with ulcerative colitis treated with colectomy and ileo-rectal anastomosis.
    Ehsanullah M; Naunton Morgan M; Filipe MI; Gazzard B
    Histopathology; 1985 Feb; 9(2):223-35. PubMed ID: 3988245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of monoclonal antibody-defined colonic mucosal antigens in inflammatory bowel disease.
    Haviland AE; Borowitz MJ; Lan MS; Kaufman B; Khorrami A; Phelps PC; Metzgar RS
    Gastroenterology; 1988 Nov; 95(5):1302-11. PubMed ID: 3049215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplasia and cancer in ulcerative colitis: a soluble problem?
    Riddell RH
    Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunoperoxidase study of epithelial marker antigens in ulcerative colitis with dysplasia and carcinoma.
    Allen DC; Biggart JD; Orchin JC; Foster H
    J Clin Pathol; 1985 Jan; 38(1):18-29. PubMed ID: 3918077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoperoxidase staining for CEA in ulcerative colitis.
    Friedman CJ; Mills SE
    J Clin Gastroenterol; 1983 Oct; 5(5):453-9. PubMed ID: 6355271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigmoidoscopy and biopsy in surveillance for cancer in ulcerative colitis.
    Fochios SE; Sommers SC; Korelitz BI
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 1):249-54. PubMed ID: 3734356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different techniques for detection of Gal-GalNAc, an early marker of colonic neoplasia.
    Said IT; Shamsuddin AM; Sherief MA; Taleb SG; Aref WF; Kumar D
    Histol Histopathol; 1999 Apr; 14(2):351-7. PubMed ID: 10212796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Nugent FW; Haggit RC; Colcher H; Kutteruf GC
    Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
    Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.